How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Portable and Wearable Dialysis Devices Market
- By Device Type: Wearable Artificial Kidney (WAK) Devices, Portable Peritoneal Dialysis Devices, Portable Hemodialysis Machines, Wearable Hemodialysis Devices
- By Dialysis Modality: Hemodialysis (HD), Peritoneal Dialysis (PD), Continuous Renal Replacement Therapy (CRRT)
- By End User: Home Care Settings, Hospitals and Clinics, Dialysis Centers, Ambulatory Care Centers
- By Technology: Continuous Flow Dialysis Technology, Batch Dialysis Technology, Sorbent-Based Dialysis Technology, Ultrafiltration Technology
- By Power Source: Battery-Powered Devices, Plug-In Electric Devices, Hybrid Power Devices
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Wearable Artificial Kidney (WAK) Devices leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Portable and Wearable Dialysis Devices Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Device Type 4
Dialysis Modality 3
End User 4
Technology 4
Power Source 3
Companies profiled
Fresenius Medical Care AG & Co. KGaA
Baxter International Inc.
Nipro Corporation
B. Braun Melsungen AG
Medtronic plc
NxStage Medical
Inc. (a subsidiary of Fresenius Medical Care)
Outset Medical Inc.
Quanta Dialysis Technologies Ltd.
Hemotech Medical Corporation
RenalSense Inc.
Diality Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Fresenius Medical Care AG & Co. KGaA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →NxStage Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Inc. (a subsidiary of Fresenius Medical Care)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Outset Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Quanta Dialysis Technologies Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Hemotech Medical Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →RenalSense Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Diality Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Deka Research & Development Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Medica S.p.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Toray Industries Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Asahi Kasei Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,267M by 2033 · 6.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wearable Artificial Kidney (WAK) Devices54.3
- Portable Peritoneal Dialysis Devices16.3
- Portable Hemodialysis Machines8.4
- Wearable Hemodialysis Devices20.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,689M → $2,671M · 5.9%
Europe$1,177M → $2,103M · 7.5%
Asia Pacific$1,075M → $1,802M · 6.7%
Latin America$665.4M → $1,066M · 6.1%
Middle East and Africa$511.8M → $900.2M · 7.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.122026
6.142027
6.152028
6.162029
6.172030
6.202031
6.202032
6.222033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Fresenius Medical Care AG & Co. KGaA14.5
- Baxter International Inc.23.5
- Nipro Corporation11.4
- B. Braun Melsungen AG7.0
- Medtronic plc9.5
- NxStage Medical6.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type26.8%
Dialysis Modality17.9%
End User10.1%
Technology22.4%
Power Source22.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.3
- Europe24.6
- Asia Pacific21.1
- Latin America12.5
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 82 | 84 | 88 | 89 | 98 | 73 | 86 |
| Baxter International Inc. | 85 | 90 | 74 | 78 | 84 | 88 | 83 |
| Nipro Corporation | 72 | 71 | 73 | 81 | 69 | 79 | 74 |
| B. Braun Melsungen AG | 82 | 66 | 62 | 76 | 72 | 82 | 73 |
| Medtronic plc | 67 | 73 | 57 | 52 | 67 | 58 | 62 |
| NxStage Medical | 50 | 46 | 57 | 65 | 69 | 71 | 60 |
| Inc. (a subsidiary of Fresenius Medical Care) | 57 | 40 | 41 | 50 | 58 | 59 | 51 |
| Outset Medical Inc. | 52 | 56 | 57 | 39 | 37 | 45 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Fresenius Medical Care AG & Co. KGaA
- Baxter International Inc.
- Nipro Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Baxter International Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Nipro Corporation | − | ✓ | ◐ | ◐ | ◐ | ✓ |
| B. Braun Melsungen AG | ◐ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Medtronic plc | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| NxStage Medical | − | − | − | ◐ | ◐ | ✓ |
| Inc. (a subsidiary of Fresenius Medical Care) | ◐ | − | − | ◐ | − | − |
| Outset Medical Inc. | ◐ | ◐ | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Fresenius Medical Care AG & Co. KGaA86
2Baxter International Inc.83
3Nipro Corporation74
4B. Braun Melsungen AG73
5Medtronic plc62
6NxStage Medical60
7Inc. (a subsidiary of Fresenius Medical Care)51
8Outset Medical Inc.48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Fresenius Medical Care AG & Co. KGaABaxter International Inc.
Challenger2
Strong scale, closing on the leaders.
Nipro CorporationB. Braun Melsungen AG
Contender2
Focused players with pockets of strength.
Medtronic plcNxStage Medical
Niche2
Specialists in a single segment or region.
Inc. (a subsidiary of Fresenius Medical Care)Outset Medical Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Portable and Wearable Dialysis Devices Market — a $407M beachhead inside a $6.03B market.
Beachhead (SOM)$407Mobtainable near-term
Serviceable (SAM)$2.28Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Wearable Artificial Kidney (WAK) Devices
Best fit — highest urgency & budget in Device Type.
Economic buyer78 fit
Portable Peritoneal Dialysis Devices
Strong fit — clear ROI and a fast path to value.
End user69 fit
Portable Hemodialysis Machines
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Dialysis Modality & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Portable and Wearable Dialysis Devices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified26%
Evaluation14%
Closed-won7%
$17.6KCAC
$85KLTV
4.9:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Portable and Wearable Dialysis Devices Market is a resilient opportunity — $2.21B by 2033, compounding at 4.7%.
TAM · 2025$1.53Btoday
TAM · 2033$2.21Bforecast
CAGR4.7%2027–2033
Cumulative$16.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.21BTotal addressable market
SAM$795MServiceable available market
SOM$166MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.7% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.21BLarge & growingTAM by 2033 at 4.7% CAGR
$795MServiceable nowreachable with today’s model
$166MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.73BBear3.0% CAGR
$2.21BBase4.7% CAGR
$2.83BBull6.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Dialysis Modality optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Portable and Wearable Dialysis Devices Market — a $7.38B market by 2033. Plan: grow share from 11.3% to 18.2%.
Market size · 2033$7.38Btotal addressable
Market CAGR3.6%2027–2033
Target share18.2%from 11.3% today
Revenue ambition$1.34Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.3% | 18.2% | At risk |
| Revenue | $753M | $1.34B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.8% | 40.3% | On track |
| Customer retention | 86.0% | 94.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Dialysis Modality capability
A defensible second engine — invest in Dialysis Modality to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Dialysis Modality
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $197M capacity & capability investment
- Greenlight bolt-on M&A in Dialysis Modality
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Portable and Wearable Dialysis Devices Market conversation — a $6.21B market you can size, segment and defend in minutes.
Market size · 2033$6.21Btotal opportunity
Growth11.3%CAGR to 2033
Addressable buyers1,107+accounts in scope
Typical ROI6.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.8×return on cost, year one
< 2 mopayback period
$80K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Fresenius Medical Care AG & Co. KGaABaxter International Inc.Nipro CorporationB. Braun Melsungen AGMedtronic plcNxStage MedicalInc. (a subsidiary of Fresenius Medical Care)Outset Medical Inc.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Portable and Wearable Dialysis Devices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Portable and Wearable Dialysis Devices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Portable Anesthesia Delivery Machine Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportPortable CT Scanners Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPortable Digital Electronic Colposcope Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPortable ECG Devices Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportPrescription Dermatological Drugs Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportClavulanic Acid Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportContact Lenses Wiping Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportSolid Tumors Drugs Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSulfachloropyridazine Sodium Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportSulfadiazine Sodium Injection Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportSulfasalazine Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportSulindac Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.